Please use analysis of Pd Rx Pharmaceutical fundamentals to determine if markets are correctly pricing the firm. We were able to interpolate data for twenty-six available financial indicators for Pd-Rx Pharmaceutical, which can be compared to its peers in the sector. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Pd-Rx Pharmaceutical to be traded at $3.3 in 90 days.
Pd-Rx
Please note, the imprecision that can be found in Pd-Rx Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pd Rx Pharmaceutical. Check Pd-Rx Pharmaceutical's Beneish M Score to see the likelihood of Pd-Rx Pharmaceutical's management manipulating its earnings.
Pd-Rx Pharmaceutical Stock Summary
Pd-Rx Pharmaceutical competes with Unidoc Health, and Devonian Health. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. Pd-Rx Pharmaceutical operates under Medical Distribution classification in the United States and is traded on OTC Exchange.
Pd-Rx Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Pd-Rx Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Pd-Rx Pharmaceutical over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Pd-Rx Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Pd-Rx Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pd-Rx Pharmaceutical competition to find correlations between indicators driving Pd-Rx Pharmaceutical's intrinsic value. More Info.
Pd Rx Pharmaceutical is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pd Rx Pharmaceutical is roughly 4.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pd-Rx Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pd-Rx Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Pd-Rx Pharmaceutical February 15, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pd-Rx Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pd Rx Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pd Rx Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Pd-Rx Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pd-Rx Pharmaceutical's daily price indicators and compare them against related drivers.
When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.